Covered recipient · General Payments record
KATAYOUN OMRANI
Dental Providers Dentist Orofacial Pain
General Payments · PY2018–2024
$2,971.59
- Reported across 148 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $847.49 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lundbeck LLC | $166.50 | 9 |
| Teva Pharmaceuticals USA, Inc. | $147.79 | 2 |
| PFIZER INC. | $138.96 | 9 |
| Janssen Biotech, Inc. | $117.89 | 5 |
| AIMMUNE THERAPEUTICS, INC. | $88.07 | 3 |
| ABBVIE INC. | $60.89 | 2 |
| QOL Medical, LLC | $46.76 | 2 |
| Regeneron Healthcare Solutions, Inc. | $37.63 | 1 |
| Nevro Corp. | $25.87 | 1 |
| Ardelyx, Inc. | $17.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.32 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105154613 | CMS |
| ABBVIE INC. | $26.57 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105154615 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $30.39 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146965840 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $28.43 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146978394 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $29.25 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146991580 | CMS |
| Ardelyx, Inc. | $17.13 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146698677 | CMS |
| Janssen Biotech, Inc. | $22.86 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078306166 | CMS |
| Janssen Biotech, Inc. | $23.36 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078305864 | CMS |
| Janssen Biotech, Inc. | $21.09 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078307354 | CMS |
| Janssen Biotech, Inc. | $28.09 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078306258 | CMS |
| Janssen Biotech, Inc. | $22.49 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078307898 | CMS |
| Lundbeck LLC | $19.21 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145952509 | CMS |
| Lundbeck LLC | $6.58 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145952511 | CMS |
| Lundbeck LLC | $4.74 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145952513 | CMS |
| Lundbeck LLC | $20.95 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145952515 | CMS |
| Lundbeck LLC | $6.46 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145952517 | CMS |
| Lundbeck LLC | $22.40 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145952519 | CMS |
| Lundbeck LLC | $27.02 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145952521 | CMS |
| Lundbeck LLC | $29.27 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145952523 | CMS |
| Lundbeck LLC | $29.87 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145952525 | CMS |
| Nevro Corp. | $25.87 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130784419 | CMS |
| PFIZER INC. | $23.44 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131564402 | CMS |
| PFIZER INC. | $3.07 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131992499 | CMS |
| PFIZER INC. | $23.13 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131587419 | CMS |
| PFIZER INC. | $6.95 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131922111 | CMS |
| PFIZER INC. | $27.20 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131595144 | CMS |
| PFIZER INC. | $21.47 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131778246 | CMS |
| PFIZER INC. | $7.56 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131926362 | CMS |
| PFIZER INC. | $18.94 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131926534 | CMS |
| PFIZER INC. | $7.20 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131964905 | CMS |
| QOL Medical, LLC | $18.64 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147731306 | CMS |
| QOL Medical, LLC | $28.12 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147731308 | CMS |
| Regeneron Healthcare Solutions, Inc. | $37.63 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114127774 | CMS |
| Teva Pharmaceuticals USA, Inc. | $120.17 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151601640 | CMS |
| Teva Pharmaceuticals USA, Inc. | $27.62 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151601626 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.